Drug maker Novo Nordisk expects lower U.S. prices next year
Novo Nordisk, the world's top maker of diabetes drugs, on Wednesday reported second-quarter operating profit broadly in line with forecasts, but said prices in the key U.S. market would be lower next year.
from Reuters: Health News https://reut.rs/2M4MTyz
http://bit.ly/2zwRqiM